156 results
Page 3 of 8
8-K
EX-99.1
7436rb6g8jr
3 Mar 22
Aravive Announces Positive Updated Data and New Biomarker Data
7:06am
8-K
EX-99.1
k7bs8bhijnnv9hy1monq
31 Jan 22
Aravive Announces First Patient Dosed in Phase 2 Study
7:05am
8-K
EX-99.1
my3 sac4dn4elwg
12 Nov 21
7 of 16 (44%) patients achieved best overall response of partial response
7:06am
8-K
EX-99.1
1xmbvl
9 Nov 21
3 of 5 (60%) patients achieved a partial response All 5 patients treated demonstrated tumor decrease from baseline
8:29am
8-K
EX-99.1
p6u50wj6
28 Oct 21
Aravive Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
4:06pm
8-K
EX-99.1
cuyyd61rc7dlxi tj8jt
9 Aug 21
Aravive Announces First Patient Dosed in Phase 1b/2 Clinical Trial of AVB-500 for the Treatment of Pancreatic Adenocarcinoma
7:09am
8-K
EX-99.1
fcg1bw2
5 Aug 21
Aravive Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
7:06am
8-K
EX-99.1
haarrkbois8ptio
15 Jul 21
Aravive Achieves Second Development Milestone from 3D Medicines
7:05am
8-K
EX-99.1
rkbev 1rie3lv
24 Jun 21
Regulation FD Disclosure
7:07am
8-K
EX-10.1
7cp7 x3dclzg
14 Jun 21
Entry into a Material Definitive Agreement
4:08pm
8-K
EX-99.1
vh5l87cevyvd
18 May 21
Aravive Announces Three New Appointments to its Board of Directors
7:05am
8-K
EX-99.1
2ffnf2 2cp5l
6 May 21
Aravive continues to expand development of AVB-500 in multiple indications and combination treatments with first-line treatment for pancreatic cancer
7:08am
8-K
EX-99.2
uft60eqpw96qpd t9xl
6 May 21
Aravive continues to expand development of AVB-500 in multiple indications and combination treatments with first-line treatment for pancreatic cancer
7:08am
8-K
EX-99.1
hpmnsz
27 Apr 21
Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant Ovarian Cancer
7:10am
8-K
EX-99.2
so5duthk35ixfcro
27 Apr 21
Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant Ovarian Cancer
7:10am
8-K
EX-99.1
4d05p6 u118jujxw
16 Mar 21
Aravive Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Updates
7:15am